Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
resB
- Development stage
- Unknown
- Lead developer
- ResBiotic
- Modality
- Live Biotherapeutic Products → Microbiome Therapeutics
- Administration
- Oral
01
Overview
resB (also known as resB Lung Support) is a probiotic dietary supplement developed by ResBiotic to support respiratory health via the gut-lung axis. The product contains a proprietary blend of three probiotic *Lactobacillus* strains (specifically *L. plantarum*, *L. acidophilus*, and *L. rhamnosus*) and three herbal extracts: turmeric (*Curcuma longa*), holy basil (*Ocimum sanctum*), and vasaka (*Adhatoda vasica*). It is designed to modulate the gut microbiome, thereby reducing systemic and pulmonary inflammation. Clinical research, including a pilot study in asthma and a randomized controlled trial in COPD, has demonstrated that resB is well-tolerated and can significantly improve respiratory symptoms (as measured by the SGRQ) and reduce inflammatory biomarkers such as matrix metalloproteinase 9 (MMP-9), C-reactive protein (CRP), and interleukin 6 (IL-6).
- Brand names
- resBresB Lung Support
- Other names
- resB Lung Support
02
Targets
MMP9 (Matrix metalloproteinase-9)IL-6 (Interleukin 6)
Beyond the preview
Go deeper on resB.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on resB.